Abbreviations: bNCSC, boundary cap neural crest stem cell; DIFF, differentiation medium; eGFP, enhanced green fluorescent protein; GFAP, glial fibrillary acidic protein; Iba-1, ionized calcium binding adaptor molecule 1; MSP, mesoporous silica particle; PBS, phosphate buffered saline; TRITC, tetramethylrhodamine-5-(and 6)-isothiocyanate; Vol, volume; Wt, weight
IntroductionMesoporous silica particles (MSPs) are characterized by ordered porosity, sharp pore size distributions, high internal surface areas, and large pore volumes. 1,2 Control over these structural parameters makes them an ideal candidate for drug encapsulation, perfectly suited to uptake and carry large amounts of drugs that then get released with constant concentration. [3][4][5] The release of the actives can be diffusion controlled or may be triggered by a change in media temperature or pH.6 Creation of simultaneous release profiles is possible by using different pore structures (e. g., 2D hexagonal and 3D cubic) that enable a continuous discharge of a fine tuned mixture of active drugs over a given period of time.MSPs have already shown potential for life science applications over traditional polymer based delivery systems. They offer increased bioavailability, biocompatibility, controlled and targeted release, reduced drug-drug interactions, the potential to deliver both lipophilic and hydrophilic drugs simultaneously, and the ability to customize release profiles for a combination of drugs. Moreover, nanoporous MSPs hold the potential to be not only a very efficient but also a cost effective drug delivery system. We previously showed that MSPs loaded with growth factor mimetics promote survival and differentiation of co-implanted neural stem cells, 7 indicating that the MSP delivery system can serve as a valuable tool for controlling differentiation of transplanted stem cells. Toxicological data from in vitro and in vivo studies suggest that unloaded MSPs have no observable harmful effects and are well tolerated. [8][9][10] However the possible influence of MSPs, used in our studies, on stem cell differentiation and on the non-neuronal response in the central nervous system has not been examined previously. Here we tested the effect of unloaded MSPs on in vitro differentiation of boundary cap neural crest stem cells (bNCSCs), a source of stem cells with remarkable therapeutic potential, and also analyzed the fate of MSPs at different time points after implantation into the spinal cord and on its surface. bNCSCs are neural crest derivatives that populate the entry/ exit points of spinal roots during embryonic development, 11,12 participate in cell migration and axon growth control at the spinal root-spinal cord interface, [13][14][15]
AbstractStem cell transplantation is an attractive strategy to counteract the progression of neurodegenerative disorders and to replace lost neuronal cells. Despite successful generation of neuronal cell types in vitro, stem cell technology typically fails when applied in vivo. One of the reasons is lack of cont...